ANCA Associated Diseases/Vasculitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
- January 2038
- Diseases & Conditions
- 0 pages
Vasculitis is an autoimmune disease in which the body comes under attack from its own immune system, especially neutrophils, and in some cases it is also caused by reactions to medicines. It is a term for a group of rare diseases that are characterized by a condition that destroys blood vessels through inflammation. It can range from mild to life threatening and short term to long term. Vasculitis is caused by leukocyte migration and can affect arteries and veins in the body. It is found in both sexes and people of all ages. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a type of vasculitis. AAV is a group of three diseases including eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, and microscopic polyangiitis.
AAV can affect small and medium blood vessels including arteries, veins, and capillaries in the body. It can cause poor blood flow to organs such as lungs, kidneys, nerves, and skin. AAV causes inflammation of blood vessels as it blocks or closes the path for blood flow, which can lead to aneurysms. The symptoms of vasculitis include shortness of breath, reddish spots on the skin, numbness, and sores. Vasculitis of the kidneys may produce no symptoms at first. However, it can lead to a serious condition. Vasculitis can be treated with immunosuppressive drugs, and its early detection and treatment can prevent permanent damage. The primary treatment for vasculitis includes the use of glucocorticoids. The dosage and the length of the treatment depends on the severity of the disease, history, and condition of the patient.
Rise in incidences of metabolic disorders and circulatory diseases and changing lifestyle are likely to increase the prevelance of this disease, driving the ANCA associated diseases/vasculitis market. However, lack of awareness is likely to restrain the ANCA Associated Diseases/Vasculitis market in the near future.
The treatment of AAV is divided into two phases. The first phase of treatment is induction of remission and the second phase of treatment is maintenance. The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treatment market can be segmented based on route of administration of drug, distribution channel, and region. Based on the route of administration of drug, the antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treatment market can be classified into parenteral, oral, nasal, and topical. The parenteral route segment accounts for a dominant share of the ANCA Associated Diseases/Vasculitis market due to higher availability and stability of the drug in the injectable form and immediate response. In terms of distribution channel, the antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treatment market can be categorized into retail store, pharmacy, and e-commerce. The e-commerce segment is expected to account for a prominent market share by 2025 due to user convenience and increase in awareness about self-medication.
Based on region, the antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the ANCA Associated Diseases/Vasculitis market owing to increased awareness and high incidences of circulatory diseases and changing lifestyle. Europe is also a prominent region of the market due to advancement in health care technologies in the region. In addition, Asia Pacific is a rapidly expanding region of the Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treatment market because of changing lifestyle, rise in population following an urban lifestyle, and significant expansion in the economy of this region.
Some of the key players engaged in developing vasculitis therapeutics ANCA Associated Diseases/Vasculitismarket are Novartis AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., RNL BIO Co., Ltd., Human Genome Sciences, Inc.¸ Johnson & Johnson’s, and Genentech, Inc. among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Diseases & Conditions
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017